A rapid-acting option for treatment-resistant depression.
Spravato® (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression and major depressive disorder with suicidal ideation. Every dose is administered in our clinic under the direct supervision of a trained provider.
FDA-approved
Approved by the FDA in 2019 as the first new depression medication of its kind in decades.
In-clinic supervision
Every dose is administered and monitored on-site by our medical team for your safety.
Works differently
Targets NMDA receptors rather than serotonin, offering a new path for those who haven't responded to SSRIs.
What to expect
Your visit, step by step.
Each Spravato session takes place in one of our private treatment suites. After self-administering the nasal spray under our supervision, you'll relax and be monitored for at least two hours before heading home with a trusted driver.
- Arrive and check in with our team
- Vitals and pre-treatment check-in
- Self-administer Spravato in a private suite
- Rest and monitoring for at least 2 hours
- Discharge with a designated driver
Is Spravato right for me?
Spravato is approved for adults who have tried at least two antidepressants without adequate relief, and for adults with major depressive disorder experiencing suicidal thoughts or actions.
Our team will complete a full evaluation and coordinate with your existing prescribers to determine if Spravato is a fit for your treatment plan.
SPRAVATO® Important Safety Information
Before starting SPRAVATO® please review the full Indication and Important Safety Information, including the Boxed Warning.
Take the next step
Relief is closer than it feels.
A short, no-pressure conversation with our team is the fastest way to find out if TMS, Spravato, or ketamine is right for you. Most insurance plans are accepted.